1. Home
  2. VYGR vs LAZR Comparison

VYGR vs LAZR Comparison

Compare VYGR & LAZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VYGR
  • LAZR
  • Stock Information
  • Founded
  • VYGR 2013
  • LAZR 2012
  • Country
  • VYGR United States
  • LAZR United States
  • Employees
  • VYGR N/A
  • LAZR N/A
  • Industry
  • VYGR Biotechnology: Pharmaceutical Preparations
  • LAZR Auto Parts:O.E.M.
  • Sector
  • VYGR Health Care
  • LAZR Consumer Discretionary
  • Exchange
  • VYGR Nasdaq
  • LAZR Nasdaq
  • Market Cap
  • VYGR 222.9M
  • LAZR 246.4M
  • IPO Year
  • VYGR 2015
  • LAZR N/A
  • Fundamental
  • Price
  • VYGR $3.16
  • LAZR $3.80
  • Analyst Decision
  • VYGR Strong Buy
  • LAZR Buy
  • Analyst Count
  • VYGR 9
  • LAZR 7
  • Target Price
  • VYGR $14.86
  • LAZR $45.29
  • AVG Volume (30 Days)
  • VYGR 396.9K
  • LAZR 3.8M
  • Earning Date
  • VYGR 05-12-2025
  • LAZR 05-06-2025
  • Dividend Yield
  • VYGR N/A
  • LAZR N/A
  • EPS Growth
  • VYGR N/A
  • LAZR N/A
  • EPS
  • VYGR N/A
  • LAZR N/A
  • Revenue
  • VYGR $80,001,000.00
  • LAZR $75,395,000.00
  • Revenue This Year
  • VYGR N/A
  • LAZR $17.39
  • Revenue Next Year
  • VYGR $2.04
  • LAZR $53.70
  • P/E Ratio
  • VYGR N/A
  • LAZR N/A
  • Revenue Growth
  • VYGR N/A
  • LAZR 8.05
  • 52 Week Low
  • VYGR $2.75
  • LAZR $3.30
  • 52 Week High
  • VYGR $9.55
  • LAZR $34.80
  • Technical
  • Relative Strength Index (RSI)
  • VYGR 38.34
  • LAZR 38.28
  • Support Level
  • VYGR $2.75
  • LAZR $3.30
  • Resistance Level
  • VYGR $3.34
  • LAZR $5.18
  • Average True Range (ATR)
  • VYGR 0.26
  • LAZR 0.48
  • MACD
  • VYGR 0.03
  • LAZR -0.18
  • Stochastic Oscillator
  • VYGR 41.41
  • LAZR 19.84

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

About LAZR Luminar Technologies Inc.

Luminar Technologies Inc is an automotive technology company ushering in a new era of vehicle safety and autonomy. It operates its business through the following segments: Autonomy Solutions and advanced Technologies and Services. The majority of revenue is earned from the Autonomy Solutions segment which engaged in the design, manufacturing, and sale of LiDAR sensors catering mainly to the OEMs in the automobile, commercial vehicle, robo-taxi, and adjacent industries and advanced Technologies and Services provides semiconductors and related components, as well as design, test and consulting services to the Autonomy Solutions segment and various third-party customers, including government agencies and defense contractors, in markets generally unrelated to autonomous vehicles.

Share on Social Networks: